BORIS regulates tumor initiation and progression through various mechanisms, including competitively binding to CTCF's DNA targets and interfering with CTCF function, participating in epigenetic regulation, and promoting the generation of tumor stem cells (Pugacheva et al. 2024). The gene discussed is CTCFL; the disease is neoplasm.